Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05512221 · ClinicalTrials.gov registry record · NA
Transdiagnostic Group Therapy (GBAT) for Autistic Adults With Personalized Therapeutics
A NA study of GBAT+Individual and GBAT+Engagement Booster, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT05512221 is a NA study of GBAT+Individual and GBAT+Engagement Booster that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 33 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05512221, a NA study of GBAT+Individual and GBAT+Engagement Booster, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to build upon an earlier study that evaluated the use of a 10-week transdiagnostic Group Behavioral Activation Therapy (GBAT), a telehealth delivered intervention, as a cost effective and accessible way to treat symptoms of anxiety and depression in autistic adults. The current study will pilot and compare relative feasibility, acceptability, and preliminary efficacy of three adapted GBAT groups and a Watchful Waiting (WW) group. The three groups include GBAT+Individual (GBAT+I; individual sessions to supplement the 10 group sessions), GBAT+Engagement Booster (GBAT+E; supplemental materials), and GBAT+Both (GBAT+IE individual sessions and supplemental materials).
Conditions Studied
Interventions
- OTHER GBAT+I, GBAT+E - Phase I
- OTHER Watchful Waiting and Groups - Phase 2
- OTHER GBAT+IE
Study Locations (1)
New Jersey
- Rutgers University - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2022-09-23 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05512221
The ClinicalTrials.gov registry entry for NCT05512221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with GBAT+Individual appearing as the primary indexed condition, and to 3 interventions - of which GBAT+I, GBAT+E - Phase I is the first listed.
NCT05512221 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05512221 about?
NCT05512221 is a clinical study titled "Transdiagnostic Group Therapy (GBAT) for Autistic Adults With Personalized Therapeutics". The purpose of this study is to build upon an earlier study that evaluated the use of a 10-week transdiagnostic Group Behavioral Activation Therapy (GBAT), a telehealth delivered intervention, as a cost effective and accessible way to treat symptoms of anxiety and depression in autistic adults. The ...
What is the current status of trial NCT05512221?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2022-09-23. Estimated completion is 2024-07-01.
What conditions does trial NCT05512221 study?
This clinical trial studies the following conditions: GBAT+Individual, GBAT+Engagement Booster, GBAT+Both.
What interventions are being tested in trial NCT05512221?
The interventions under investigation include: GBAT+I, GBAT+E - Phase I (OTHER), Watchful Waiting and Groups - Phase 2 (OTHER), GBAT+IE (OTHER).
Who is sponsoring clinical trial NCT05512221?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05512221 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.